Correlation Between Aldel Financial and Tscan Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aldel Financial and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldel Financial and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldel Financial II and Tscan Therapeutics, you can compare the effects of market volatilities on Aldel Financial and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldel Financial with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldel Financial and Tscan Therapeutics.

Diversification Opportunities for Aldel Financial and Tscan Therapeutics

0.41
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aldel and Tscan is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Aldel Financial II and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Aldel Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldel Financial II are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Aldel Financial i.e., Aldel Financial and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between Aldel Financial and Tscan Therapeutics

Assuming the 90 days horizon Aldel Financial II is expected to generate 0.02 times more return on investment than Tscan Therapeutics. However, Aldel Financial II is 44.92 times less risky than Tscan Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.05 per unit of risk. If you would invest  998.00  in Aldel Financial II on August 28, 2024 and sell it today you would earn a total of  3.00  from holding Aldel Financial II or generate 0.3% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aldel Financial II  vs.  Tscan Therapeutics

 Performance 
       Timeline  
Aldel Financial II 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Aldel Financial II are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Aldel Financial is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Aldel Financial and Tscan Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aldel Financial and Tscan Therapeutics

The main advantage of trading using opposite Aldel Financial and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldel Financial position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.
The idea behind Aldel Financial II and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine